The inquiry, obtained first by CNBC, highlights mounting political and regulatory scrutiny surrounding the intersection of commercial prediction markets and public health oversight. Platforms such as Kalshi and Polymarket have expanded their financial offerings into the biopharmaceutical sector, allowing retail and institutional participants to wager on the outcomes of complex medical research and federal drug […]
Ripple has announced that it expects to close out 2026 with an annualized product revenue run rate of US$900 million. The company shared this significant financial milestone during its annual Ripple Swell 2026 conference, held in New York. This projection follows closely on the heels of a major regulatory milestone achieved just days prior, when […]